Sally Kolta

Sally Kolta is a highly experienced professional with a strong educational background. She holds a Master of Business Administration (MBA) with a focus on Finance from Northwestern University - Kellogg School of Management. Additionally, she completed her Bachelor of Business Administration in Finance at The American University in Cairo and participated in a Study Abroad Program in Economics at the University of California, Los Angeles.

Sally has held various key positions in well-established organizations. She is currently the Director of Venture Capital and Corporate Business Development at Eli Lilly and Company. Previously, she served as the Director of Corporate Finance and Investment Banking and as a Business Transformation Consultant within the same company. Prior to that, Sally was the CFO North America Oncology at Eli Lilly and Company. She also gained valuable experience in Private Banking and Asset Management at J.P. Morgan. Before joining Eli Lilly and J.P. Morgan, Sally worked at Beltone Financial as the Head of MENA Telecoms Sector in Sell-Side Equity Research and as an Analyst in Sell-Side Equity Research. She began her career as an Analyst in the Macro Fiscal Unit at the Ministry of Finance of Egypt.

Sally Kolta's diverse professional background and leadership roles reflect her expertise in finance, business development, investment banking, corporate finance, venture capital, and consultancy. Her international exposure through academic programs and work experiences in various sectors such as healthcare, finance, and telecommunications has equipped her with a broad perspective and strategic insights to drive organizational success.